Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.79 |
| ▸ | CES1 | P23141 | 3/20 | 0.77 |
| ▸ | CES2 | O00748 | 1/20 | 0.77 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.77 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.77 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.77 |
| ▸ | POLB | P06746 | 3/20 | 0.76 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.76 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.76 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.76 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.76 |
| ▸ | PTPRC | P08575 | 2/20 | 0.76 |
| ▸ | PTPRF | P10586 | 2/20 | 0.76 |
| ▸ | F3 | P13726 | 2/20 | 0.76 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.76 |
| ▸ | ACP1 | P24666 | 2/20 | 0.76 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.76 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.76 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beta-Amyrin SCHEMBL17124229 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL1696465 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL12313094 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL18687837 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL377754 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL14828378 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL1696463 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL3119711 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL18376076 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 | |
| Beta-Amyrin SCHEMBL14226156 | 1.00 | USP2 (1.00) | USP2ALOX5CES1CES2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2536288-B1 | A NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS | LAILA NUTRACEUTICALS (IN) | 2022-06-22 | — | — | EP | claimed |
| US-20190175678-A1 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT | LAILA NUTRA PRIVATE LIMITED (IN) | 2019-06-13 | — | — | US | claimed |
| US-10206964-B2 | Synergistic anti-inflammatory compositions comprising Boswellia serrata extract | LAILA NUTRACEUTICALS (IN) | 2019-02-19 | — | — | US | claimed |
| US-20150290270-A1 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT | LAILA NUTRACEUTICALS | 2015-10-15 | — | — | US | claimed |
| US-9101599-B2 | Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts | LAILA NUTRACEUTICALS (US) | 2015-08-11 | — | — | US | claimed |
| US-8551496-B2 | Boswellia low polar gum resin extract and its synergistic compositions | LAILA NUTRACEUTICALS (IN) | 2013-10-08 | — | — | US | claimed |
| US-20120301432-A1 | NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS | LAILA NUTRACEUTICALS (IN) | 2012-11-29 | — | — | US | claimed |
| US-20110159120-A1 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS | LAILA NUTRACEUTICALS (IN) | 2011-06-30 | — | — | US | claimed |
| WO-2010029578-A2 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS | GOKARAJU GANGA RAJU (IN) | 2010-03-18 | — | — | WO | claimed |
| WO-2008071169-A2 | METHOD FOR THE PRODUCTION OF SPECIFIC INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE, IN PARTICULAR TYPE 1 WITH BASIC NOR-OLEANAN OR NOR-URSAN FRAMEWORKS | UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN (DE) | 2008-06-19 | — | — | WO | claimed |
| EP-2536288-B1 | A NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS | LAILA NUTRACEUTICALS (IN) | 2022-06-22 | — | — | EP | disclosed |
| US-20190175678-A1 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT | LAILA NUTRA PRIVATE LIMITED (IN) | 2019-06-13 | — | — | US | disclosed |
| US-10286023-B2 | Compositions comprising non-acidic Boswellia oil fraction as a bio-enhancer for enhancing bioavailability of biological agents | LAILA NUTRACEUTICALS (IN) | 2019-05-14 | — | — | US | disclosed |
| US-10206964-B2 | Synergistic anti-inflammatory compositions comprising Boswellia serrata extract | LAILA NUTRACEUTICALS (IN) | 2019-02-19 | — | — | US | disclosed |
| US-9795646-B2 | Boswellia oil, its fractions and compositions for enhancing brain function | LAILA NUTRACEUTICALS (IN) | 2017-10-24 | — | — | US | disclosed |
| EP-1711194-B1 | A PLANT EXTRACT AND ITS PHARMACEUTICAL AND COSMETIC USE | COGNIS FRANCE SAS (FR) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008071169-A2 | METHOD FOR THE PRODUCTION OF SPECIFIC INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE, IN PARTICULAR TYPE 1 WITH BASIC NOR-OLEANAN OR NOR-URSAN FRAMEWORKS | UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN (DE) | 2008-06-19 | — | — | WO | disclosed |
| US-20070281047-A1 | Composition Containing a Plant Extract and Process for Producing Same | COGNIS FRANCE, S.A.S. (FR) | 2007-12-06 | — | — | US | disclosed |
| EP-1711194-A1 | A PLANT EXTRACT AND ITS PHARMACEUTICAL AND COSMETIC USE | Cognis France, S.A.S. (FR) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005039610-A1 | A PLANT EXTRACT AND ITS PHARMACEUTICAL AND COSMETIC USE | COGNIS FRANCE, S.A.S. (FR) | 2005-05-06 | — | — | WO | disclosed |